We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Artios Pharma

News List

Merck KGaA signs deal with Artios Pharma for cancer drugs research expresspharma
December 07, 2020
Artios will receive $30 million in up-front and near-term payments, plus double-digit option fees and up $860 million total milestones per target.
Artios Pharma announces $84 M Series B financing biospectrumasia
August 14, 2018
Financing Round Led by New Investors Andera Partners and LSP
Artios Pharma raises £65m to develop DDR therapies pharmatimes
August 13, 2018
Cambridge-based biotech Artios Pharma has raised £65 million in series B financing from investors including Pfizer and Novartis, to further its development DNA Damage Response (DDR) therapies for cancer.